Cargando…

THE RET/PTC-3 ONCOGENE ACTIVATES CLASSICAL NF-κB BY STABILIZING NIK

The oncogenic fusion protein RET/PTC3 (RP3) that is expressed in papillary thyroid carcinoma (PTC) and thyroid epithelia in Hashimoto’s thyroiditis activates Nuclear Factor-kappa B (NF-κB) and induces pro-inflammatory gene expression; however, the mechanism of this activation is unknown. To address...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neely, Robert J., Brose, Marcia S., Gray, Carolyn M., McCorkell, Kelly A., Leibowitz, Jason M, Ma, Changqing, Rothstein, Jay L., May, Michael J.
Formato:	Texto
Lenguaje:	English
Publicado:	2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000456/ https://www.ncbi.nlm.nih.gov/pubmed/20818435 http://dx.doi.org/10.1038/onc.2010.396

Ejemplares similares

DNA Breaks at Fragile Sites Generate Oncogenic RET/PTC Rearrangements in Human Thyroid Cells
por: Gandhi, Manoj, et al.
Publicado: (2010)

A study to evaluate association of nuclear grooving in benign thyroid lesions with RET/PTC1 and RET/PTC3 gene translocation
por: Ashwini, Basavaraj Rangalakshmi, et al.
Publicado: (2023)

Assessment of RET/PTC1 and RET/PTC3 rearrangements in fine-needle aspiration biopsy specimens collected from patients with Hashimoto's thyroiditis
por: Cyniak-Magierska, Anna, et al.
Publicado: (2011)

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
por: de Martimprey, Henri, et al.
Publicado: (2008)

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
por: de Martimprey, Henri, et al.
Publicado: (2008)

Radiation exposure, young age, and female gender are associated with high prevalence of RET/PTC1 and RET/PTC3 in papillary thyroid cancer: a meta-analysis
por: Su, Xuan, et al.
Publicado: (2016)

A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions
por: Estrada-Zuniga, Cynthia M., et al.
Publicado: (2022)

ret/PTC-1 expression alters the immunoprofile of thyroid follicular cells
por: Denning, Karen, et al.
Publicado: (2008)

Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC
por: Kim, Young-Rae, et al.
Publicado: (2008)

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
por: Romei, Cristina, et al.
Publicado: (2012)

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes
por: Endo, Toyoshi, et al.
Publicado: (2013)

Effects of siRNA on RET/PTC3 Junction Oncogene in Papillary Thyroid Carcinoma: From Molecular and Cellular Studies to Preclinical Investigations
por: Ali, Hafiz Muhammad, et al.
Publicado: (2014)

Catalytic subunits of the phosphatase calcineurin interact with NF-κB-inducing kinase (NIK) and attenuate NIK-dependent gene expression
por: Shinzawa, Miho, et al.
Publicado: (2015)

Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene
por: Monaco, Mario, et al.
Publicado: (2018)

RET/PTC and CK19 Expression in Papillary Thyroid Carcinoma and Its Clinicopathologic Correlation
por: Shin, Eunah, et al.
Publicado: (2005)

APPL1 regulates basal NF-κB activity by stabilizing NIK
por: Hupalowska, Anna, et al.
Publicado: (2012)

Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
por: Pflug, Kathryn M., et al.
Publicado: (2020)

NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway
por: Xiang, Jianyang, et al.
Publicado: (2022)

Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.
por: Mayr, B., et al.
Publicado: (1998)

Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice
por: Jin, L, et al.
Publicado: (2008)

Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice
por: Jin, L, et al.
Publicado: (2009)

Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model
por: Cahill, Susanne, et al.
Publicado: (2006)

MON-514 Detection of RAS Mutations and RET/PTC Fusions in Thyroid Cancer Using Microfluidic Digital PCR
por: Ylli, Dorina, et al.
Publicado: (2020)

Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
por: Santoro, M., et al.
Publicado: (1993)

Plug in with Nik software: a photographer's guide to creating dynamic images with Nik software
por: Batdorff, John
Publicado: (2013)

Glucocorticoids increase skeletal muscle NF‐κB inducing kinase (NIK): links to muscle atrophy
por: Fry, Christopher S., et al.
Publicado: (2016)

A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB
por: Liu, Zixu, et al.
Publicado: (2019)

Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements
por: Mechler, C, et al.
Publicado: (2001)

A Multifocal Pediatric Papillary Thyroid Carcinoma (PTC) Harboring the AGK-BRAF and RET/PTC3 Fusion in a Mutually Exclusive Pattern Reveals Distinct Levels of Genomic Instability and Nuclear Organization
por: Sisdelli, Luiza, et al.
Publicado: (2021)

Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
por: Moccia, Marialuisa, et al.
Publicado: (2015)

DNA Topoisomerases Participate in Fragility of the Oncogene RET
por: Dillon, Laura W., et al.
Publicado: (2013)

Alterations of RET, Oncogene in Human Adrenal Tumors
por: Lin, Shiu‐Ru, et al.
Publicado: (1998)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Roles of the RET Proto-oncogene in Cancer and Development
por: Takahashi, Masahide, et al.
Publicado: (2020)

Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line
por: Caccia, Dario, et al.
Publicado: (2010)

NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action
por: Sheng, Liang, et al.
Publicado: (2012)

NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes
por: Xiao, Peng, et al.
Publicado: (2022)

NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK
por: Cormier, Françoise, et al.
Publicado: (2023)

BRAF(V600E) and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB
por: Zhou, Dehua, et al.
Publicado: (2017)

NF-kappaB inducing kinase (NIK) is a key regulator of inflammation-induced angiogenesis
por: Noort, Ae-Ri, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dqitq12bv0b4en5i7rqvum6q5i